PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Title only   |   Print    Next page > 
     
Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer
Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases. Minimizes instrument and user differences ...
2026-09-14T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Results from Phase III Study of Trastuzumab Botidotin versus T-DM1 in HER2-Positive Breast Cancer Published in JCO
CHENGDU, China , Sept. 14, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or "the Company", 6990.HK) announced that results from the ...
2026-09-14T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
NUS scientists harness magnetic pulses to reprogram immune cells to fight breast cancer
An innovative approach for breast cancer treatment uses localised and non-invasive pulsed electromagnetic fields to reprogram immune cells, turning them from tumour helpers to cancer killers ...
2026-09-14T    Education   Health Care/Hospital   Higher Education   Medical/Pharmaceuticals 
Tomonari Abe, President of Abe Yoando Pharma, Selected as First Japanese Speaker at Longevity Investors Conference 2026 in Switzerland
- Head of 295-year-old Japanese Pharmaceutical Pioneer to Present Asia's Longevity Growth Strategies and Bioscientific Research Initiatives at Prestigious Conference - ...
2026-09-14T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Antengene Publishes Preclinical Research Paper on CD73 Small Molecule Inhibitor ATG-037 Combined with Selinexor in Cancer Gene Therapy
SHANGHAI and HONG KONG , Sept. 14, 2026 /PRNewswire/ -- Antengene Corporation Limited  ( "Antengene" , SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated ...
2026-09-14T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Sorbent to acquire Kenvue's Stayfree and Carefree business in Australia and New Zealand
MELBOURNE, Australia , Sept. 14, 2026 /PRNewswire/ -- Sorbent P aper Company Pty Ltd ("Sorbent") has signed an agreement with Kenvue's Singaporean subsidiary to acquire its Stayfree and Carefree ...
2026-09-14T    Banking/Financial Service   Health Care/Hospital   Household/Consumer/Cosmetics 
Accro Bioscience Announces Inclusion of AC-101 tablets in the NMPA CDE's "Caring Plan-Extension" Pilot Program for Rare Disease Drug Development
NEW YORK and SUZHOU, China , Sept. 14, 2026 /PRNewswire/ -- On September 14, 2026 (China Standard Time, UTC+8), Accro Bioscience announced tha t AC-101 tablets have been included in the Rare Diseases ...
2026-09-14T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
FDA Approves Telix's Brain Cancer Imaging Drug Pixclara
Pixclara® is the first FDA-approved FET-PET imaging drug for glioma (brain cancer). Approval addresses a significant unmet need, helping physicians to differentiate recurrent or progressive glioma ...
2026-09-14T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
IonOpticks launches Aurora Series® 5 and new CoreJet™ emitter technology, advancing robust nano-LC for routine proteomics research.
New CoreJet ™ integrated emitter technology and a redesigned nanoZero ® union combine proven Aurora Series ® performance with a step-change in robustness, lowering cost per sample ...
2026-09-14T    Health Care/Hospital   Medical Equipment 
Ivonescimab Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC: Positive Overall Survival Results from HARMONi-2 Presented at WCLC 2026
HONG KONG , Sept. 13, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced the presentation of positive overall survival (OS) results from the randomized, double-blind, multicenter, registrational ...
2026-09-13T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.